Evaluation of HBsAg, Anti-HCV Seroprevalence and Hepatitis B Immunity in Pregnant Women: A Descriptive Study

Öner, Sedef Zeliha; Kalipci, İrem; Okur, Asuman

doi:10.29058/mjwbs.828591

Cited by 2 publications

(1 citation statement)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, anti-HBs positivity was significantly higher in the ≤24 age group, as expected. As in this study, Özcan Dağ et al 9 , Erin et al 23 , Şahin et al 25 , and Öner et al 27 reported that the rate of anti-HBs positivity was higher in young pregnant women and attributed this to the success of the national vaccination program.…”

Section: Discussionsupporting

confidence: 63%

Determination of hepatitis B and hepatitis C seroprevalence in pregnant women in the Kastamonu region, Turkey

Tüfekci¹,

Çalışır²,

Yaşar-Duman³

et al. 2023

KMJ

View full text Add to dashboard Cite

Aims: Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections during pregnancy have a risk of transmission to the newborn. Therefore, pregnant women are routinely screened for HBV and HCV in many countries. This study aimed to reveal the seroprevalence of HBsAg, anti-HBs, and anti-HCV in pregnant women in the Kastamonu region and to compare the obtained data with the results of studies conducted in Turkey. Methods: Pregnant women who applied to Kastamonu Training and Research Hospital Microbiology laboratory between January 2022 and January 2023 for HBsAg, anti-HBs, and anti-HCV tests were included in this study. The pregnant women were separated into two groups ?24 and >24 age groups. The tests were performed using the chemiluminescence microparticle immune assay method on the Abbott Architect i2000SR instrument, and the results were evaluated per the manufacturer’s instructions. Results: HBsAg, anti-HBs, and anti-HCV positivity were 0.5% (n=9/1712), 51.1% (n=874/1712), and 0.1% (n=2/1713), respectively. While there was no significant difference between age groups for HBsAg positivity (p>0.05), anti-HBs positivity was found to be significantly higher in the ?24 age group than in the >24 age group (p=0.002). Conclusion: The results showed that HBsAg and anti-HCV positivity was lower than in most studies conducted in recent years in Turkey, and anti-HBs positivity was higher than in most studies. It is essential to continue routine HBV and HCV screening in pregnant women’s first follow-up and encourage anti-HBs-negative individuals to be vaccinated against HBV.

show abstract

Section: Discussionsupporting

confidence: 63%

Determination of hepatitis B and hepatitis C seroprevalence in pregnant women in the Kastamonu region, Turkey

Tüfekci¹,

Çalışır²,

Yaşar-Duman³

et al. 2023

KMJ

View full text Add to dashboard Cite

show abstract

Bir Eğitim ve Araştırma Hastanesinde polikliniğe başvuran gebelerde konjenital infeksiyon etkenlerinin seroprevalansının araştırılması

AYDOĞMUŞ

2022

Ankara Eğitim Ve Araştırma Hastanesi Tıp Dergisi

View full text Add to dashboard Cite

Amaç: Bu çalışmada, gebe kadınlarda konjenital infeksiyon etkenlerinden TORCH Grubunun seropozitifliğinin araştırılması amaçlandı. Gereç ve Yöntem: Çalışmaya 2020-11/2022 yılları arasında başvuran 20-46 yaşları arasındaki 1000 gebe dahil edildi. Retrospektif olarak incelendi. Testler ELISA yöntemiyle çalışıldı. Bulgular: Çalışmaya katılan 1000 gebe yaş ortalaması 28,07± 5,9 olup en küçüğü 20, en büyüğü ise 46 yaşındaydı. Gebelerin ortalama gebelik haftası 13,35±9,2 hf idi. Toplam 1000 gebenin 1000‘inde (%100) Anti HIV antikoru negatifti. 1000 gebenin 991 ‘inde (%99,1) HBsAg negatif, 9’unda (%0,9) pozitifti. 27 gebenin (%100) Anti CMV IgG değeri pozitifti. 43 gebenin 7 ‘sinde (%16,3) Anti Rubella IgG negatif, 36’sında (%83,7) pozitifti. 314 gebenin 312 ‘inde (% 99,36) Anti Toxoplazma IgM negatif, 2’sinde (%0,6) pozitifti. Sonuç: Gebelerde Rubella- IgG, CMV-IgG seropozitiflik oranları ile HBsAg pozitifliği oranları Türkiye verileri ile benzer olduğu saptandı. AntiHBs antikor oranının yüksek, Anti Toxoplazma IgG pozitiflik oranının (%17,1) ise Türkiye ortalamasından daha düşük olduğu saptandı. Gebelerin aşıyla önlenebilen Hepatit B , Rubella infeksiyon etkenleri için, seronegatif gebelerin uygun zamanda aşılanması gerekir. Ayrıca, T.gondii bulaş yolları gebelere anlatılarak, gelişebilecek yenidoğan mortalite ve morbidite oranlarını azaltacağı görüşündeyiz. Anahtar kelimeler: Gebelik, T.gondii, CMV, Rubella, Hepatit B, HIV, seroprevalans

show abstract

Evaluation of HBsAg, Anti-HCV Seroprevalence and Hepatitis B Immunity in Pregnant Women: A Descriptive Study

Cited by 2 publications

References 17 publications

Determination of hepatitis B and hepatitis C seroprevalence in pregnant women in the Kastamonu region, Turkey

Determination of hepatitis B and hepatitis C seroprevalence in pregnant women in the Kastamonu region, Turkey

Bir Eğitim ve Araştırma Hastanesinde polikliniğe başvuran gebelerde konjenital infeksiyon etkenlerinin seroprevalansının araştırılması

Contact Info

Product

Resources

About